Galanin overexpressing transgenic mice

被引:42
作者
Crawley, JN
Mufson, EJ
Hohmann, JG
Teklemichael, D
Steiner, RA
Holmberg, K
Xu, ZQD
Blakeman, KH
Xu, XJ
Wiesenfeld-Hallin, Z
Bartfai, T
Hökfelt, T
机构
[1] NIMH, Sect Behav Genom, NIH, Bethesda, MD 20892 USA
[2] Rush Presbyterian St Lukes Med Ctr, Dept Neurol Sci, Chicago, IL 60612 USA
[3] Rush Presbyterian St Lukes Med Ctr, Rush Alzheimers Dis Ctr, Chicago, IL 60612 USA
[4] Univ Washington, Sch Med, Dept Obstet & Gynecol, Seattle, WA 98195 USA
[5] Univ Washington, Sch Med, Dept Physiol & Biophys, Seattle, WA 98195 USA
[6] Karolinska Inst, Dept Neurosci, S-17177 Stockholm, Sweden
[7] Huddinge Univ Hosp, Karolinska Inst, Clin Neurophysiol Sect, S-14186 Huddinge, Sweden
[8] Karolinska Inst, Dept Biochem & Biophys, S-17177 Stockholm, Sweden
[9] Scripps Res Inst, Res Inst, Dept Neuropharmacol, Harold L Dorris Neurol Res Ctr, La Jolla, CA 92037 USA
关键词
D O I
10.1054/npep.2002.0891
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Galanin overexpressing transgenic mice (GAL-tg) were generated on two different promoters. Both lines of GAL-tg displayed high levels of galanin in the hippocampus and reduced sensitivity to seizures, as compared to their respective wildtype littermate controls (WT). Performance deficits on learning and memory tasks, impaired long-term potentiation, reduced hippocampal excitability, lower evoked glutamate release, and reduced numbers of choline acetyltransferase immunoreactive neurons in the horizontal limb of the diagonal band were detected in GAL-tg as compared to WT. Changes in sensitivity to nociceptive stimuli were demonstrated in one line. GAL-tg represent a new model for investigating the biological actions of endogenous galanin, and for testing novel therapeutics based on galanin receptor ligands. (C) 2002 Elsevier Science Ltd. All rights reserved.
引用
收藏
页码:145 / 156
页数:12
相关论文
共 78 条
[1]   SAGE identification of gene transcripts with profiles unique to pluripotent mouse R1 embryonic stem cells [J].
Anisimov, SV ;
Tarasov, KV ;
Tweedie, D ;
Stern, MD ;
Wobus, AM ;
Boheler, KR .
GENOMICS, 2002, 79 (02) :169-176
[2]   GALANIN AND GALANIN ANTAGONISTS - MOLECULAR AND BIOCHEMICAL PERSPECTIVES [J].
BARTFAI, T ;
FISONE, G ;
LANGEL, U .
TRENDS IN PHARMACOLOGICAL SCIENCES, 1992, 13 (08) :312-317
[3]   GALANIN IMMUNOREACTIVITY IS INCREASED IN THE NUCLEUS BASALIS OF MEYNERT IN ALZHEIMERS-DISEASE [J].
BEAL, MF ;
MACGARVEY, U ;
SWARTZ, KJ .
ANNALS OF NEUROLOGY, 1990, 28 (02) :157-161
[4]   GALANIN PROTECTS HIPPOCAMPAL-NEURONS FROM THE FUNCTIONAL-EFFECTS OF ANOXIA [J].
BENARI, Y ;
LAZDUNSKI, M .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1989, 165 (2-3) :331-332
[5]   GALANIN IMMUNOREACTIVITY WITHIN THE PRIMATE BASAL FOREBRAIN - EVOLUTIONARY CHANGE BETWEEN MONKEYS AND APES [J].
BENZING, WC ;
KORDOWER, JH ;
MUFSON, EJ .
JOURNAL OF COMPARATIVE NEUROLOGY, 1993, 336 (01) :31-39
[6]   ANXIOLYTIC-LIKE ACTION OF CENTRALLY ADMINISTERED GALANIN [J].
BING, O ;
MOLLER, C ;
ENGEL, JA ;
SODERPALM, B ;
HEILIG, M .
NEUROSCIENCE LETTERS, 1993, 164 (1-2) :17-20
[7]   Mice over-expressing galanin have elevated heat nociceptive threshold [J].
Blakeman, KH ;
Holmberg, K ;
Hao, JX ;
Xu, XJ ;
Kahl, U ;
Lendahl, U ;
Bartfai, T ;
Wiesenfeld-Hallin, Z ;
Hökfelt, T .
NEUROREPORT, 2001, 12 (02) :423-425
[8]  
BLAKEMAN KH, 2002, IASP 10 WORLD C PAIN
[9]   A confocal microscopic analysis of galaninergic hyperinnervation of cholinergic basal forebrain neurons in Alzheimer's disease [J].
Bowser, R ;
Kordower, JH ;
Mufson, EJ .
BRAIN PATHOLOGY, 1997, 7 (02) :723-730
[10]   NEUROPATHOLOGICAL STAGING OF ALZHEIMER-RELATED CHANGES [J].
BRAAK, H ;
BRAAK, E .
ACTA NEUROPATHOLOGICA, 1991, 82 (04) :239-259